ArticleAntimicrobial agents and chemotherapy2018
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of
Open access · bronzeAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.
- Aspergillus fumigatus-a systematic review to inform the World Health Organization priority list of fungal pathogens.Medical mycology · 2024Pooled it
- Activity of Isavuconazole and Comparator Agents Against Pediatric Isolates From Invasive Fungal Infections.Journal of the Pediatric Infectious Diseases Society · 2026Article
- Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance.The Journal of antimicrobial chemotherapy · 2026Article
- Genetic analysis of common triazole resistance mechanisms in a collection ofAntimicrobial agents and chemotherapy · 2025Article
- Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction inJournal of clinical microbiology · 2025Article
- Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction inJournal of clinical microbiology · 2025Article
- Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?Journal of fungi (Basel, Switzerland) · 2024Review
- Importance of theJournal of fungi (Basel, Switzerland) · 2024Article
- Drug Susceptibility Test and Analysis of Quinolone Resistance Genes inInfection and drug resistance · 2023Article
- Article
- Species Distribution and Antifungal Susceptibilities ofJournal of clinical microbiology · 2022Article
- Treatment of a Pulmonary Aspergilloma in a Lung Transplant Recipient Using Catheter-directed Intracavitary Instillation of Liposomal Amphotericin B.Transplantation direct · 2022Article
- Antifungal Susceptibility Testing: A Primer for Clinicians.Open forum infectious diseases · 2021Review
- Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).The Journal of antibiotics · 2021Article
- Exploration of Clinical Breakpoint of Danofloxacin forAntibiotics (Basel, Switzerland) · 2021Article
- In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles.Journal of fungi (Basel, Switzerland) · 2021Article
- A Novel Combination ofAntimicrobial agents and chemotherapy · 2020Article
- Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.Journal of fungi (Basel, Switzerland) · 2019Review
- Epidemiology and Antifungal Susceptibility Profile ofJournal of clinical microbiology · 2019Article
- Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance inAntimicrobial agents and chemotherapy · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 20 institutions in 16 countries.
A Espinel-IngroffVCU Medical Center, Richmond, Virginia, USA victoria.ingroff@vcuhealth.org.
J TurnidgeUniversity of Adelaide, Adelaide, Australia.
A Alastruey-IzquierdoMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.ORCID 0000-0001-8651-4405
E DannaouiUniversité Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.ORCID 0000-0002-2817-3830
G Garcia-EffronLaboratorio de Micología y Diagnóstico Molecular-Facultad de Bioquímica y Ciencias Biológicas-Universidad Nacional del Litoral, Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT, Santa Fe, Argentina.
J GuineaServicio de Microbiología Clínica y Enfermedades Infecciosas-VIH, Hospital General Universitario Gregorio Marañon, and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.ORCID 0000-0002-7901-8355
S KiddNational Mycology Reference Centre, Microbiology & Infectious Diseases, SA Pathology, Adelaide, Australia.
T PelaezServicio de Microbiología, Hospital Universitario Central de Asturias, Asturias, Spain.
M SanguinettiInstitute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy.
J MeletiadisClinical Microbiology Laboratory, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
F BotterelUnité de Parasitologie-Mycologie, Département de Virologie, Bactériologie-Hygiène, Parasitologie-Mycologie, DHU VIC, CHU Henri Mondor, Créteil, France.
B BustamanteInstituto de Medicina Tropical Alexander von Humboldt-Universidad Peruana Cayetano Heredia, Lima, Peru.
Y-C ChenDepartment of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
A ChakrabartiDepartment of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
A ChowdharyDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
E ChryssanthouKlinisk Mikrobiologi, Karolinska, Universitetlaboratoriet, Karolinska, Universitetssjukhuset, Stockholm, Sweden.
S CórdobaInstituto Nacional de Enfermedades Infecciosas Dr. C. G. Malbrán, Buenos Aires, Argentina.
G M GonzalezUniversidad Autonóma de Nuevo León, Monterrey, Nuevo León, México.
J GuarroMycology Unit Medical School, Universitat Rovira i Virgili, Reus, Spain.
E M JohnsonMycology Reference Laboratory, Public Health England, Bristol, United Kingdom.
J V KusPublic Health Ontario, Toronto, Ontario, Canada.
C Lass-FlörlNational Mycology Reference Centre, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
M J Linares-SiciliaUniversidad de Córdoba, H. G. U. Reina Sofía, Córdoba, Spain.
E Martín-MazuelosUnidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología, Hospital de Valme, Seville, Spain.
C E NegriUniversidade Federal de São Paulo, Laboratório Especial de Micologia, São Paulo, Brazil.
M A PfallerUniversity of Iowa College of Medicine, Iowa City, Iowa, USA.
A M TortoranoDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0003-2093-8250
Administración Nacional de Laboratorios e Institutos de Salud · ARCentre Hospitalier Universitaire Henri-Mondor · FRConsejo Nacional de Investigaciones Científicas y Técnicas · ARHospital General Universitario Gregorio Marañón · ESHospital Universitario Central de Asturias · ESHospital Universitario de Valme · ESInnsbruck Medical University · ATInstituto de Salud Carlos III · ESKarolinska University Hospital · SENational and Kapodistrian University of Athens · GRNational Taiwan University Hospital · TWPost Graduate Institute of Medical Education and Research · INPublic Health England · GBPublic Health Ontario · CASouth Australia Pathology · AUThe University of Adelaide · AUUniversidad Autónoma de Nuevo León · MXUniversidade Federal de São Paulo · BRUniversidad Peruana Cayetano Heredia · PEUniversità Cattolica del Sacro Cuore · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for mutant and nonmutant strains (strains harboring or not harboring mutations, respectively). Posaconazole MIC distributions for the
Indexed as
Antifungal AgentsAspergillus fumigatusDrug Resistance, FungalMicrobial Sensitivity TestsMutationTriazolesVoriconazoleAntifungal AgentsposaconazoleTriazolesVoriconazoleAspergillus fumigatusCLSI ECVscyp51A mutantsECVsEtestEUCAST ECVsposaconazoleSYOtriazole resistancewild type
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.